Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Nanoscale Horiz. 2021 Feb 15;6(4):319–329. doi: 10.1039/d0nh00588f

Scheme 1.

Scheme 1.

Schematic illustration of the mechanism of pCCL2 trap for the treatment of TNBC in murine model of TNBC. A. Primary mammary breast tumor immunosuppressive TME constitutes of surrounding tumor associated adipocyte (TAA) and infiltrated immunocytes. B. pCCL2 trap successfully remodels the immunosuppressive TME of TNBC in the tumor model.